<bill session="115" type="s" number="3000" updated="2019-07-16T21:20:11Z">
  <state datetime="2018-06-06">REFERRED</state>
  <status>
    <introduced datetime="2018-06-06"/>
  </status>
  <introduced datetime="2018-06-06"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to make improvements to the transparency report requirements under section 1128G of such Act.</title>
    <title type="short" as="introduced">Patient Advocacy Transparency Act</title>
    <title type="short" as="introduced">Patient Advocacy Transparency Act</title>
    <title type="display">Patient Advocacy Transparency Act</title>
  </titles>
  <sponsor bioguide_id="M001170"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-06-06">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-06-06" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-06T04:00:00Z" status="Introduced in Senate">Patient Advocacy Transparency Act

This bill expands the scope of transparency reports submitted by manufacturers of covered drugs, devices, and medical supplies under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).</summary>
  <committee-reports/>
</bill>
